Pulmonary Thromboembolisms: Clinical Trials

1 trial for Pulmonary Thromboembolisms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Pulmonary Thromboembolisms: new trials by email Literature Review of Pulmonary Thromboembolisms trials Research Report on Pulmonary Thromboembolisms

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE
Conventional catheter-directed thrombolysis (CDT) with recombinant tissue plasminogen activator (rtPA), Enoxaparin - Pulmonary Embolism, Pulmonary Thromboembolisms
Phase 3TerminatedRajaie Cardiovascular Medical and Research Center942018-12-222021-12-29

Narrower conditions

Pulmonary Embolism (1)  ·  Ventricular Dysfunction, Right (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Embolism (1)  ·  Embolism and Thrombosis (1)  ·  Heart Diseases (1)  ·  Lung Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Vascular Diseases (1)  ·  Ventricular Dysfunction (1)

Interventions

Enoxaparin (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  carbohydrate-deficient transferrin (1)

Sponsors

Rajaie Cardiovascular Medical and Research Center (1)

Countries

Iran (1)

Top investigators

Parham Sadeghipour, M.D (1)

Results publications

PMID 36260302